Robert E. Dudley - Dec 12, 2021 Form 4 Insider Report for Clarus Therapeutics Holdings, Inc. (CRXT)

Role
Chief Executive Officer, Director
Signature
/s/ Steven A. Bourne, attorney-in-fact
Stock symbol
CRXT
Transactions as of
Dec 12, 2021
Transactions value $
$0
Form type
4
Date filed
12/14/2021, 06:00 PM
Previous filing
Sep 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRXT Common Stock Award $0 +135K +2956.64% $0.00 140K Dec 12, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRXT Stock Option (Right to Buy) Award $0 +338K $0.00 338K Dec 12, 2021 Common Stock 338K $4.78 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 135,000 shares on 12/12/2021, of which 25% vest on 9/9/2022, and the remaining shares vest in 36 equal monthly installments thereafter subject to the Reporting Person continuing to have a service relationship as of each such vesting date.
F2 These options were granted under the 2021 Plan and vest (i) 25% on 9/9/2022 and (ii) with the remainder vesting in 36 equal monthly installments thereafter subject to the Reporting Person continuing to have a service relationship as of each such vesting date.